======= DPYS =======
== Gene Information ==
* **Official Symbol**: DPYS
* **Official Name**: dihydropyrimidinase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1807|1807]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q14117|Q14117]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=DPYS&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DPYS|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/613326|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: Dihydropyrimidinase catalyzes the conversion of 5,6-dihydrouracil to 3-ureidopropionate in pyrimidine metabolism. Dihydropyrimidinase is expressed at a high level in liver and kidney as a major 2.5-kb transcript and a minor 3.8-kb transcript. Defects in the DPYS gene are linked to dihydropyrimidinuria. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyze the ring opening of 5,6- dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate.
|Amidohydro 1|
|thymine binding|
|uracil binding|
|uracil catabolic process|
|uracil metabolic process|
|thymine metabolic process|
|thymine catabolic process|
|beta-alanine metabolic process|
|dihydropyrimidinase activity|
|pyrimidine nucleobase catabolic process|
|nucleobase catabolic process|
|amino acid binding|
|pyrimidine nucleobase metabolic process|
|pyrimidine nucleoside catabolic process|
|phosphoprotein binding|
|nucleoside catabolic process|
|pyrimidine nucleoside metabolic process|
|nucleobase metabolic process|
|pyrimidine-containing compound catabolic process|
|glycosyl compound catabolic process|
|nucleobase-containing small molecule catabolic process|
|neurotransmitter metabolic process|
|protein homotetramerization|
|pyrimidine-containing compound metabolic process|
|nucleoside metabolic process|
|glycosyl compound metabolic process|
|drug catabolic process|
|protein tetramerization|
|carbohydrate derivative catabolic process|
|cellular amino acid metabolic process|
|protein homooligomerization|
|regulation of neurotransmitter levels|
|nucleobase-containing compound catabolic process|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|small molecule catabolic process|
|aromatic compound catabolic process|
|organic cyclic compound catabolic process|
|drug metabolic process|
|protein complex oligomerization|
|nucleobase-containing small molecule metabolic process|
|zinc ion binding|
|carboxylic acid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|organonitrogen compound catabolic process|
|protein-containing complex assembly|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|protein-containing complex subunit organization|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp504|MK2206 4μM R08 exp504]]|1.76|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 14221
* **Expression level (log2 read counts)**: -7.68
{{:chemogenomics:nalm6 dist.png?nolink |}}